Latest news
News and updates
Stay informed with the latest breakthroughs in macular research, emerging treatments for sight loss, and inspiring stories from the people we support. Browse our most recent news and insights below—and sign up to our free monthly enewsletter to never miss an update.
New research investigates immune system's role in AMD
Posted: Monday 31 October 2022
New research is looking into a specific part of the immune system, called the ‘complement system’, which, when damaged, can lead to age-related macular degeneration (AMD).
Find out more
Experts unite to find a cure for dry AMD
Posted: Friday 21 October 2022
Global experts in macular disease will meet in the US this month to speed up the progress being made to find a cure for dry age-related macular degeneration (AMD).
Find out more
Participants needed for Charles Bonnet research
Posted: Saturday 1 October 2022
Scientists want to understand more about how visual hallucinations caused by sight loss impact the daily lives of those affected.
Find out more
Drug shows potential to slow down dry AMD progression
Posted: Thursday 29 September 2022
A new drug being trialled in patients with dry age-related macular degeneration (AMD) has been shown to reduce the rate of progression of the disease in its late stages.
Find out more
Gene therapy trial tests injection lasting three years
Posted: Friday 23 September 2022
A new clinical trial is underway to test a gene therapy which could treat wet age-related macular degeneration (AMD), with an eye injection lasting up to three years.
Find out more
Faricimab - all you need to know about the new treatment for wet AMD and DMO
Posted: Tuesday 30 August 2022
"There's a long way to go but I'm more optimistic. I was thinking of retiring a few years ago, now I'm so excited about the treatments we can offer patients I'll probably stay another few years."
Find out more
Thousands of patients with diabetes-related sight loss given access to new treatment
Posted: Thursday 11 August 2022
Thousands of patients with diabetic macular oedema (DMO) could benefit from a steroid treatment, which has previously only been available to those who have received cataract surgery.
Find out more
"It could be life-changing for so many people"
Posted: Wednesday 3 August 2022
A 75-year-old man involved in a clinical trial for a new implant for wet age-related macular degeneration (AMD) says it would be ‘magic’ if the trial is successful.
Find out more
Ophthalmologist to reveal more about new drug for two types of macular disease
Posted: Wednesday 3 August 2022
An ophthalmologist who has worked on the clinical trials for the latest drug approved to treat wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO) will reveal more about the treatment and how you can access it, as part of the Macular Society’s monthly webinar series.
Find out more
New treatment option approved for patients with diabetic macular oedema
Posted: Thursday 28 July 2022
Patients living with diabetes-related sight loss could be treated with a new drug, following a recommendation from The National Institute for Health and Care Excellence (NICE).
Find out more
Cheaper drugs for wet AMD becoming available on the NHS
Posted: Tuesday 19 July 2022
New forms of anti-VEGF drugs will soon be available to treat wet age-related macular degeneration (AMD) thanks to the production of biosimilars.
Find out more
Gene editing to treat inherited macular disease
Posted: Tuesday 5 July 2022
A research team is making strides in using gene-editing techniques to treat a rare, inherited form of macular disease.
Find out more
Get the latest news and advice from the Macular Society
To hear about life-changing research, treatments and tips for living with sight loss, subscribe to our monthly enewsletter today. Together we can Beat Macular Disease.
Sign up to our free email newsletter